MINDKIND PHARMA#MANKIND Pharma Limited
TF: 30 min
Pattern: Inverted head and shoulder
Buying range: in between 2680-2708 Targets: 2770, 2840, 2910
SL: 30 min candle closing below 2645
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
52.80 INR
19.13 B INR
103.34 B INR
64.52 M
About MANKIND PHARMA LTD
Sector
CEO
Sheetal Arora
Headquarters
New Delhi
Website
Founded
1986
ISIN
INE634S01028
FIGI
BBG01G9WXG92
Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. It offers products under the brands of Nurokind, Telmikind, Manforce, Unwanted, Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Prega News, Dydroboon, Cefakind, Monticope, and Caldikind. The company was founded by Ramesh Chand Juneja in 1986 and is headquartered in New Delhi, India.
MANKIND
Stock is in an up-trend, and recent clearance of its previous all time high of 2490 confirms that.
The stock has a low price history, so cannot predict targets.
Riding the up-trend is the most sensible decision here.
Bullish outlook remains intact as long as the price trades in the up-sloping
Mankind Pharma Ltd - Cup with handle pattern formationThe cup with handle pattern is a bullish chart formation resembling a cup with a slight consolidation (handle) on the right. A trading strategy involves entering a position when the price breaks above the resistance level at the top of the cup, ideally after confirming bullish momentum.
Mankind Ph
Mankind Pharma... Very powerfulMankind pharma is running since its IPO opened. It has never looked back and it seems to repeat itself in future.
I think there is no target, Only SL. The chart is self-explanatory. You can make your new position even from this level and enjoy the ride.
Note : This is my view, don't go blindly as
MANKIND -Flag and Pole -Daily - Breakout **Mankind Pharma Ltd.** shows a clear **flag and pole pattern**, indicating a potential continuation of the uptrend. Here's a breakdown of the technical analysis:
### Key Observations:
1. **Flag and Pole Pattern**:
- The pattern consists of a sharp upward movement (the pole) followed by a cons
Breakout - Mankind Pharma Ltd (MANKIND) Mankind Pharma Ltd (MANKIND)
Wait for Breakout
Price Action: The stock has been trending higher since the breakout, indicating a bullish momentum.
Disclaimer: This is for informational purposes only and does not constitute financial advice. Always do your own research and consult with a finan
You can make a long position in this.It has already crossed the Fibonacci level of 2477 and it is expected that it will again test the Rs 2470 level when one can add positions in it which can be seen up to 2800 and 3400.
Buy Mankind Pharma for major upside . 2 lakh to 2 Cr journey Cmp 2300
Buy near 2280
short term target 2408 &2495
Now take a look of Long term journey
Mankind Pharma cam be a multibagger counter
5 years Sales, profit and return of equity growth almost more than 20% and this can be increase more and more .
Counter going to reach at 1 lakh cr capital this year
VIEW ON MANKIND PHARMASomething big is happening or going to happen in this stock
Continously green candle for 10 trading session
Despite of market volatility and Negative trend
I am just representing my views
Fort educational purpose only.
Momentum InvestingRule 1 : Respect Target & Stoploss.
Rule 2 : Hold the Trade until the Rule 1 is not met.
Rule 3 : SL on Day Close Basis
Rule 4 : On result day trail your SL at 15Min Time Frame
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MANKIND is 2,628.35 INR — it has increased by 1.01% in the past 24 hours. Watch MANKIND PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange MANKIND PHARMA LIMITED stocks are traded under the ticker MANKIND.
MANKIND stock has fallen by −2.68% compared to the previous week, the month change is a −1.66% fall, over the last year MANKIND PHARMA LIMITED has showed a 43.00% increase.
We've gathered analysts' opinions on MANKIND PHARMA LIMITED future price: according to them, MANKIND price has a max estimate of 3,300.00 INR and a min estimate of 2,275.00 INR. Watch MANKIND chart and read a more detailed MANKIND PHARMA LIMITED stock forecast: see what analysts think of MANKIND PHARMA LIMITED and suggest that you do with its stocks.
MANKIND reached its all-time high on Nov 6, 2024 with the price of 2,882.75 INR, and its all-time low was 1,240.75 INR and was reached on May 22, 2023. View more price dynamics on MANKIND chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MANKIND stock is 3.04% volatile and has beta coefficient of 0.13. Track MANKIND PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is MANKIND PHARMA LIMITED there?
Today MANKIND PHARMA LIMITED has the market capitalization of 1.06 T, it has decreased by −2.78% over the last week.
Yes, you can track MANKIND PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
MANKIND PHARMA LIMITED is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
MANKIND earnings for the last quarter are 16.30 INR per share, whereas the estimation was 14.71 INR resulting in a 10.78% surprise. The estimated earnings for the next quarter are 12.80 INR per share. See more details about MANKIND PHARMA LIMITED earnings.
MANKIND PHARMA LIMITED revenue for the last quarter amounts to 30.77 B INR, despite the estimated figure of 30.41 B INR. In the next quarter, revenue is expected to reach 33.92 B INR.
MANKIND net income for the last quarter is 6.53 B INR, while the quarter before that showed 5.36 B INR of net income which accounts for 21.80% change. Track more MANKIND PHARMA LIMITED financial stats to get the full picture.
No, MANKIND doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 19.54 K employees. See our rating of the largest employees — is MANKIND PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MANKIND PHARMA LIMITED EBITDA is 27.29 B INR, and current EBITDA margin is 24.98%. See more stats in MANKIND PHARMA LIMITED financial statements.
Like other stocks, MANKIND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MANKIND PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MANKIND PHARMA LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MANKIND PHARMA LIMITED stock shows the neutral signal. See more of MANKIND PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.